Insider Trading activities at United Therapeutics Corp (UTHR) , Part 9

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of United Therapeutics Corp (UTHR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of United Therapeutics Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1082554.

Total stock buying since 2014: $2,421.
Total stock sales since 2014: $992,168,269.
Total stock option exercises since 2014: $541,822,297.


17 insiders reported insider trading activities at United Therapeutics Corp (UTHR):
Insider trading activities of Ferrari John Maxim
Insider trading activities of Olian Judy D.
Insider trading activities of Patusky Christopher
Insider trading activities of Causey Christopher
Insider trading activities of Mesa Nilda
Insider trading activities of Mahon Paul A
Insider trading activities of Rothblatt Martine A
Insider trading activities of Sullivan Louis W
Insider trading activities of Giltner Richard
Insider trading activities of Thompson Tommy G
Insider trading activities of Kurzweil Ray
Insider trading activities of Edgemond James
Insider trading activities of Zaccardelli David
Insider trading activities of Dwek Raymond
Insider trading activities of Benkowitz Michael
Insider trading activities of Klein Katherine J
Insider trading activities of Jeffs Roger

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at United Therapeutics Corp (UTHR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 298,681 $98,413,513 329,650 $44,142,057
2024 0 $0 1,080,734 $314,251,568 1,231,106 $160,776,403
2023 0 $0 674,662 $159,162,310 721,300 $79,733,210
2022 0 $0 378,059 $91,947,533 472,058 $45,933,490
2021 0 $0 93,229 $18,587,617 371,129 $26,110,200
2020 0 $0 400,544 $47,619,629 532,234 $32,146,564
2019 4 $331 146,548 $16,411,075 256,758 $12,814,416
2018 6 $684 290,817 $32,898,842 473,576 $25,462,128
2017 11 $1,406 78,883 $10,238,193 300,992 $12,565,750
2016 0 $0 169,661 $20,540,225 386,549 $16,198,165
2015 0 $0 1,124,315 $178,337,438 1,820,201 $84,490,835
2014 0 $0 32,211 $3,760,326 32,211 $1,449,079


Table 3. Detailed insider trading at United Therapeutics Corp (UTHR) , Part 9
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-12 Rothblatt Martine A (Chairman & CEO) Sale 1,263 120.20 151,812
2017-10-12 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-10-05 Causey Christopher (Director) Sale 580 122.00 70,760
2017-10-05 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-10-05 Rothblatt Martine A (Chairman & CEO) Sale 1,256 122.89 154,354
2017-10-05 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-09-28 Rothblatt Martine A (Chairman & CEO) Sale 1,265 119.76 151,497
2017-09-28 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-09-21 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-09-21 Rothblatt Martine A (Chairman & CEO) Sale 1,274 116.59 148,539
2017-09-21 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-09-14 Rothblatt Martine A (Chairman & CEO) Sale 1,258 122.21 153,736
2017-09-14 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-09-07 Causey Christopher (Director) Sale 580 134.48 77,998
2017-09-07 Causey Christopher (Director) Option Ex 750 54.77 41,077
2017-09-07 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-09-07 Rothblatt Martine A (Chairman & CEO) Sale 1,232 133.38 164,321
2017-09-07 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-08-31 Rothblatt Martine A (Chairman & CEO) Sale 1,235 130.49 161,156
2017-08-31 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-08-24 Rothblatt Martine A (Chairman & CEO) Sale 1,238 130.65 161,738
2017-08-24 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-08-17 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-08-17 Rothblatt Martine A (Chairman & CEO) Sale 1,235 132.26 163,336
2017-08-17 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-08-10 Rothblatt Martine A (Chairman & CEO) Sale 2,176 127.11 276,587
2017-08-10 Rothblatt Martine A (Chairman & CEO) Option Ex 3,106 30.75 95,509
2017-08-04 Dwek Raymond (Director) Option Ex 2,000 51.77 103,540
2017-08-03 Causey Christopher (Director) Sale 580 127.48 73,938
2017-08-03 Causey Christopher (Director) Option Ex 750 54.77 41,077
2017-08-03 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-08-03 Rothblatt Martine A (Chairman & CEO) Sale 1,248 126.89 158,363
2017-08-03 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-07-28 Patusky Christopher Buy 3 128.35 385
2017-07-27 Rothblatt Martine A (Chairman & CEO) Sale 1,247 127.81 159,375
2017-07-27 Rothblatt Martine A (Chairman & CEO) Option Ex 3,105 30.75 95,478
2017-07-20 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 57.15 342,900
2017-07-20 Rothblatt Martine A (Chairman & CEO) Sale 1,236 131.62 162,683
2017-07-20 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-07-17 Patusky Christopher Buy 3 130.24 390
2017-07-13 Rothblatt Martine A (Chairman & CEO) Sale 1,238 130.37 161,400
2017-07-13 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-07-06 Causey Christopher (Director) Sale 590 132.61 78,239
2017-07-06 Causey Christopher (Director) Option Ex 750 54.77 41,077
2017-07-06 Dwek Raymond (Director) Option Ex 2,000 51.77 103,540
2017-07-06 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 54.26 325,560
2017-07-06 Rothblatt Martine A (Chairman & CEO) Sale 1,234 132.48 163,485
2017-07-06 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-07-05 Giltner Richard (Director) Sale 3,490 131.12 457,608
2017-06-29 Rothblatt Martine A (Chairman & CEO) Sale 1,237 130.94 161,970
2017-06-29 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-06-23 Dwek Raymond (Director) Sale 3,490 131.71 459,667
2017-06-22 Rothblatt Martine A (Chairman & CEO) Sale 1,234 132.44 163,434
2017-06-22 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-06-21 Olian Judy D. (Director) Option Ex 3,490 .00 0
2017-06-21 Giltner Richard (Director) Option Ex 3,490 .00 0
2017-06-21 Thompson Tommy G (Director) Option Ex 2,400 27.39 65,724
2017-06-21 Causey Christopher (Director) Option Ex 3,490 .00 0
2017-06-21 Dwek Raymond (Director) Option Ex 3,490 .00 0
2017-06-21 Patusky Christopher (Director) Option Ex 1,750 .00 0
2017-06-21 Sullivan Louis W (Director) Option Ex 1,750 .00 0
2017-06-21 Kurzweil Ray (Director) Option Ex 1,750 .00 0
2017-06-15 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-06-15 Rothblatt Martine A (Chairman & CEO) Sale 1,238 130.21 161,193
2017-06-15 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-06-08 Rothblatt Martine A (Chairman & CEO) Sale 1,240 129.78 160,923
2017-06-08 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-06-01 Causey Christopher (Director) Option Ex 750 54.77 41,077
2017-06-01 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-06-01 Rothblatt Martine A (Chairman & CEO) Sale 1,251 124.48 155,719
2017-06-01 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-05-25 Rothblatt Martine A (Chairman & CEO) Sale 1,265 119.94 151,726
2017-05-25 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-05-18 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-05-18 Rothblatt Martine A (Chairman & CEO) Sale 1,261 120.72 152,232
2017-05-18 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-05-11 Rothblatt Martine A (Chairman & CEO) Sale 1,259 122.15 153,786
2017-05-11 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-05-04 Causey Christopher (Director) Option Ex 1,250 53.27 66,587
2017-05-04 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-05-04 Rothblatt Martine A (Chairman & CEO) Sale 1,258 122.41 153,988
2017-05-04 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-04-27 Rothblatt Martine A (Chairman & CEO) Sale 1,262 120.78 152,421
2017-04-27 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-04-20 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-04-20 Rothblatt Martine A (Chairman & CEO) Sale 1,260 121.14 152,632
2017-04-20 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-04-13 Rothblatt Martine A (Chairman & CEO) Sale 1,258 122.12 153,624
2017-04-13 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-04-06 Causey Christopher (Director) Option Ex 1,250 53.27 66,587
2017-04-06 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-04-06 Rothblatt Martine A (Chairman & CEO) Sale 1,257 122.58 154,076
2017-04-06 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-03-30 Rothblatt Martine A (Chairman & CEO) Sale 1,230 134.22 165,090
2017-03-30 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-03-23 Rothblatt Martine A (Chairman & CEO) Sale 1,219 139.41 169,940
2017-03-23 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-03-22 Thompson Tommy G (Director) Sale 2,000 139.37 278,740
2017-03-22 Thompson Tommy G (Director) Option Ex 2,000 54.77 109,540
2017-03-16 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-03-16 Rothblatt Martine A (Chairman & CEO) Sale 1,218 140.83 171,527
2017-03-16 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-03-09 Patusky Christopher (Director) Option Ex 3,000 48.11 144,330
2017-03-09 Rothblatt Martine A (Chairman & CEO) Sale 1,206 146.77 177,009
2017-03-09 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-03-02 Causey Christopher (Director) Option Ex 1,250 53.27 66,587
2017-03-02 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-03-02 Rothblatt Martine A (Chairman & CEO) Sale 1,203 148.27 178,373
2017-03-02 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-02-23 Rothblatt Martine A (Chairman & CEO) Sale 1,208 145.06 175,236
2017-02-23 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-02-16 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-02-16 Rothblatt Martine A (Chairman & CEO) Sale 1,173 167.92 196,965
2017-02-16 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-02-09 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-02-02 Causey Christopher (Director) Option Ex 1,250 53.27 66,587
2017-02-02 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 51.37 308,220
2017-02-02 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-01-26 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-01-19 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 53.62 321,720
2017-01-19 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2017-01-12 Patusky Christopher (Director) Sale 5,000 141.99 709,970
2017-01-12 Patusky Christopher (Director) Option Ex 5,000 30.75 153,750
2017-01-12 Rothblatt Martine A (Chairman & CEO) Sale 1,214 142.86 173,433
2017-01-12 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2017-01-05 Causey Christopher (Director) Option Ex 1,250 53.27 66,587
2017-01-05 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 50.09 300,540
2017-01-05 Rothblatt Martine A (Chairman & CEO) Sale 1,208 146.78 177,309
2017-01-05 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2016-12-29 Rothblatt Martine A (Chairman & CEO) Sale 1,211 143.99 174,373
2016-12-29 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2016-12-22 Rothblatt Martine A (Chairman & CEO) Sale 1,218 141.19 171,966
2016-12-22 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2016-12-15 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 50.09 300,540
2016-12-15 Rothblatt Martine A (Chairman & CEO) Sale 1,212 143.06 173,391
2016-12-15 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2016-12-08 Rothblatt Martine A (Chairman & CEO) Sale 1,236 131.18 162,133
2016-12-08 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2016-12-06 Giltner Richard (Director) Sale 5,000 133.37 666,845
2016-12-06 Giltner Richard (Director) Option Ex 5,000 41.14 205,700
2016-12-01 Causey Christopher (Director) Option Ex 1,250 51.77 64,712
2016-12-01 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 50.09 300,540
2016-12-01 Rothblatt Martine A (Chairman & CEO) Sale 1,246 126.84 158,045
2016-12-01 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2016-11-25 Rothblatt Martine A (Chairman & CEO) Sale 1,233 132.77 163,709
2016-11-25 Rothblatt Martine A (Chairman & CEO) Option Ex 2,177 30.75 66,942
2016-11-17 Mahon Paul A (EVP & General Counsel) Option Ex 6,000 50.09 300,540
2016-11-17 Rothblatt Martine A (Chairman & CEO) Sale 1,232 132.94 163,778
2016-11-17 Rothblatt Martine A (Chairman & CEO) Option Ex 2,176 30.75 66,912
2016-11-10 Patusky Christopher (Director) Sale 5,000 131.71 658,555

Insider trading activities including stock purchases, stock sales, and option exercises of UTHR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of United Therapeutics Corp (symbol UTHR, CIK number 1082554) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.